Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 401–500 of 1,000
Therapy-induced senescence through the redox lens
Robert, M., Kennedy, B. K., & Crasta, K. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103228 · Cited by 29
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer Treatment
Saleh, T., Greenberg, E. F., Faber, A. C., Harada, H., & Gewirtz, D. A. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2219 · Cited by 32
The Expression of the Senescence-Associated Biomarker Lamin B1 in Human Breast Cancer
Saleh, T., Alhesa, A., El‐Sadoni, M., Shahin, N. A., Alsharaiah, E., Shboul, S. A., Awad, H., Bloukh, S., Al-Balas, M., Alsalem, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12030609 · Cited by 30
Revisiting Epithelial Carcinogenesis
Méndez-López, L. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137437 · Cited by 30
Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices?
Ye, M., Huang, X., Wu, Q., & Liu, F. (2023) · Cancers · doi:10.3390/cancers15071927 · Cited by 29
El‐Sadoni, M., Shboul, S. A., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., Ababneh, N. A., Alotaibi, M. R., Azab, B., & Saleh, T. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04523-w · Cited by 28
Yip, H. Y. K., Shin, S., Chee, A., Ang, C., Rossello, F. J., Wong, L. H., Nguyen, L. K., & Papa, A. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00496-y · Cited by 29
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaïeb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 29
Corsi, F., Capradossi, F., Pelliccia, A., Briganti, S., Bruni, E., Traversa, E., Torino, F., Reichle, A., & Ghibelli, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031152 · Cited by 30
Olszewska, A., Borkowska, A., Granica, M., Karolczak, J., Zglinicki, B., Kiéda, C., & Waś, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.738385 · Cited by 30
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 30
Fibroblasts in cancer dormancy: foe or friend?
Dai, L., Mao, L., Zhang, W., Tang, Y.-J., Tang, Y., & Liang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01883-2 · Cited by 28
Safwan‐Zaiter, H., Wagner, N., Michiels, J., & Wagner, K. (2022) · Cells · doi:10.3390/cells11030541 · Cited by 28
Senotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
Czarnecka‐Herok, J., Śliwińska, M. A., Herok, M., Targońska, A., Strzeszewska, A., Bojko, A., Wolny, A., Mosieniak, G., & Sikora, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158288 · Cited by 29
Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care
Thompson, E. L., Pitcher, L. E., Niedernhofer, L. J., & Robbins, P. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009668 · Cited by 29
Interfering biosynthesis by nanoscale metal-organic frameworks for enhanced radiation therapy
Fu, Z., Liu, Z., Wang, J., Deng, L., Wang, H., Tang, W., & Ni, D. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122035 · Cited by 28
Jin, P., Li, X., Xia, Y., Li, H., Li, X., Yang, Z., Wang, Z., Xu, C., Fang, T., Zhou, D., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0396 · Cited by 28
Shrestha, N., Chaturvedi, P., Zhu, X., Dee, M. J., George, V., Janney, C., Egan, J. O., Liu, B., Foster, M., Marsala, L. I., et al. (2023) · Aging Cell · doi:10.1111/acel.13806 · Cited by 28
Cellular senescence primes liver fibrosis regression through Notch‐EZH2
Song, P., Duan, J., Ding, J. H., Liu, J., Fang, Z., Xu, H., Li, Z., Du, W., Xu, M., Ling, Y., et al. (2023) · MedComm · doi:10.1002/mco2.346 · Cited by 27
Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target
Wang, Y., Wang, J., Zhang, L., He, J., Ji, B., Wang, J., Ding, B., & Ren, M.-H. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18213 · Cited by 27
Jin, D., Tran, N., Thomas, N. J., & Tran, D. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223555 · Cited by 27
Therapy-Induced Senescence: Novel Approaches for Markers Identification
Pacifico, F., Magni, F., Leonardi, A., & Crescenzi, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158448 · Cited by 30
Mitochondria and chronic effects of cancer therapeutics: The clinical implications
Dominic, A., Hamilton, D. J., & Abe, J. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02313-2 · Cited by 27
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
Zhong, L., Huang, Y., He, J. G., Yang, N., Xu, B., Ma, Y., Liu, J., Tang, C., Luo, C., Wu, P., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00799-7 · Cited by 26
Cellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
Mechanisms of Senescence and Anti-Senescence Strategies in the Skin
Konstantinou, E. K., Longange, E., & Kaya, G. (2024) · Biology · doi:10.3390/biology13090647 · Cited by 35
Hallmarks of the cancer cell of origin: Comparisons with “energetic” cancer stem cells (e-CSCs)
Sotgia, F., Fiorillo, M., & Lisanti, M. P. (2019) · Aging · doi:10.18632/aging.101822 · Cited by 26
The Quest to Define and Target Cellular Senescence in Cancer
Wang, B., & Demaria, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2032 · Cited by 28
Bessa, T. C. D., Pagano, A., Moretti, A. I. S., Oliveira, P., Mendonça, S. A., Kovacic, H., & Laurindo, F. R. M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1402-y · Cited by 28
Senescence: A program in the road to cell elimination and cancer
Moiseeva, O., Guillon, J., & Ferbeyre, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.017 · Cited by 25
Softah, A., Alotaibi, M. R., Alhoshani, A., Saleh, T., Alhazzani, K., Almutairi, M. M., AlRowis, R., Alshehri, S., Albekairi, N. A., Harada, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11113066 · Cited by 26
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells
Favaretto, G., Rossi, M. N., Cuollo, L., Laffranchi, M., Cervelli, M., Soriani, A., Sozzani, S., Santoni, A., & Antonangeli, F. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03695-5 · Cited by 26
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Tsolou, A., Lamprou, I., Fortosi, A.-O., Liousia, M., Giatromanolaki, A. N., & Koukourakis, M. I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116562 · Cited by 25
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
Marengo, B., Garbarino, O., Speciale, A., Monteleone, L., Traverso, N., & Domenicotti, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7346492 · Cited by 25
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 29
Mechanisms of cancer stem cell senescence: Current understanding and future perspectives
Zhang, D., Monteiro, M. J., Liu, J., & Gu, W. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13528 · Cited by 27
Morris, A., Pagare, P. P., Li, J., & Zhang, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.014 · Cited by 25
Senescence: An Identity Crisis Originating from Deep Within the Nucleus
Olan, I., & Narita, M. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120420-013537 · Cited by 25
Transcriptional Heterogeneity of Cellular Senescence in Cancer
Junaid, M., Lee, A., Kim, J., Park, T. J., & Lim, S. B. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0036 · Cited by 27
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
RNA quality control factors nucleate Clr4/SUV39H and trigger constitutive heterochromatin assembly
Khanduja, J. S., Joh, R. I., Perez, M. M., Paulo, J. A., Palmieri, C. M., Zhang, J., Gulka, A. O. D., Haas, W., Gygi, S. P., & Motamedi, M. (2024) · Cell · doi:10.1016/j.cell.2024.04.042 · Cited by 26
Out with the old, in with the new: senescence in development
Czarkwiani, A., & Yun, M. H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.014 · Cited by 24
Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu, Q., Li, B., Sun, S., & Sun, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00282 · Cited by 24
Braumüller, H., Mauerer, B., Berlin, C., Plundrich, D., Marbach, P., Cauchy, P., Laessle, C., Biesel, E. A., Holzner, P. A., & Kesselring, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908449 · Cited by 26
Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
Wen, G.-M., Xiaoyan, X., & Pu, X. (2022) · Cells · doi:10.3390/cells11233790 · Cited by 27
Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1–DYRK1A–EGFR axis
Ma, F., Ma, Y., Liu, K., Gao, J., Li, S., Sun, X., & Li, G. (2022) · Food & Function · doi:10.1039/d2fo01188c · Cited by 24
Vitamin K: New insights related to senescence and cancer metastasis
Chen, A., Li, J., Shen, N., Huang, H., & Hang, Q. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189057 · Cited by 25
Kounatidis, D. C., Tentolouris, N., Vallianou, N. G., Mourouzis, I. S., Karampela, Ι., Stratigou, T., Rebelos, E., Kouveletsou, M., Stamatopoulos, V., Tsaroucha, E., et al. (2024) · Metabolites · doi:10.3390/metabo14070388 · Cited by 26
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Chen, Z., Wang, G., Guo, M., Zhu, N., Chen, X., Yan, Y., Li, N., & Yu, W. (2024) · Cancer Control · doi:10.1177/10732748241274196 · Cited by 25
Balamurli, G., Liew, A. Q. X., Tee, W., & Pervaiz, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103441 · Cited by 25
Senescent cells: A new Achilles’ heel to exploit for cancer medicine?
Zhang, B., Lam, E. W. ‐., & Sun, Y. (2018) · Aging Cell · doi:10.1111/acel.12875 · Cited by 24
Zhang, Z., Zhang, C., Miao, J., Wang, Z., Wang, Z., Cheng, Z., Wang, P., Chard, L. S., Lemoine, N. R., & Wang, Y. (2020) · Cells · doi:10.3390/cells9112438 · Cited by 24
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Liao, C., Xiao, Y., & Liu, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s285083 · Cited by 26
Timmins, M. A., & Ringshausen, I. (2022) · Cancers · doi:10.3390/cancers14071772 · Cited by 25
OTULIN couples WNT signaling to resistance in triple-negative breast cancer
Wang, W., & Wu, Z. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1825904 · Cited by 24
Liu, Q., Song, M., Wang, Y., Zhang, P., & Zhang, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189341 · Cited by 24
Rockfield, S., Kee, Y., & Nanjundan, M. (2019) · Oncogenesis · doi:10.1038/s41389-019-0154-y · Cited by 26
Zhang, T., Zhang, M., Yang, L., Gao, L., & Sun, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1032355 · Cited by 24
Senescence: a double-edged sword in beta-cell health and failure?
Varghese, S. S., & Dhawan, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196460 · Cited by 23
Wang, Z., Zhang, Y., Chen, S., Qu, Y., Tang, M., Wang, W., Li, W., & Gu, L. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149842 · Cited by 28
Janjetović, Z., & Slominski, A. T. (2024) · Cosmetics · doi:10.3390/cosmetics11020037 · Cited by 24
The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy
Zhang, W., Zhang, K., Shi, J., Qiu, H., Kan, C., Ma, Y., Hou, N., Han, F., & Sun, X. (2024) · Aging Cell · doi:10.1111/acel.14182 · Cited by 24
Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence
Webber, L. P., Yujra, V. Q., Vargas, P. A., Martins, M. D., SQUARIZE, C. H., & CASTILHO, R. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.019 · Cited by 25
Tamayo-Orrego, L., & Charron, F. (2019) · F1000Research · doi:10.12688/f1000research.20013.1 · Cited by 25
Oh, L., Hainaut, P. L., Blanchet, S., & Ariffin, H. (2020) · BMC Cancer · doi:10.1186/s12885-020-6599-8 · Cited by 22
Hematopoietic Reprogramming Entangles with Hematopoiesis
Wei, C., Yu, P., & Cheng, L. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.006 · Cited by 22
Saleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
Liu, Z., Fu, Z., Zhao, M., Wang, H., Ji, X., Zhou, J., Gu, W., Gu, Y., Ni, D., & Tang, W. (2024) · Nano Today · doi:10.1016/j.nantod.2023.102136 · Cited by 22
Kang, D. H., Lee, J., Im, S., & Chung, C. (2024) · Cancers · doi:10.3390/cancers16233996 · Cited by 23
Criqui, M., Qamra, A., Chu, T. W., Sharma, M., Tsao, J., Henry, D., Baršytė-Lovejoy, D., Arrowsmith, C. H., Winegarden, N. A., Lupien, M., et al. (2020) · eLife · doi:10.7554/elife.47333 · Cited by 23
Cancer Stem Cell-Inducing Media Activates Senescence Reprogramming in Fibroblasts
Perrigue, P. M., Rakoczy, M., Pawlicka, K. P., Belter, A., Giel-Pietraszuk, M., Naskręt-Barciszewska, M. Z., Barciszewski, J., & Figlerowicz, M. (2020) · Cancers · doi:10.3390/cancers12071745 · Cited by 22
F-box proteins in cancer stemness: An emerging prognostic and therapeutic target
Khan, A. Q., Al-Tamimi, M., Shahab Uddin, M. S., & Steinhoff, M. S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.006 · Cited by 23
Therapy-induced senescence is finally escapable, what is next?
Saleh, T. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2364579 · Cited by 24
Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis
Rolver, M. G., Roda, J. C., Dai, Y., Flinck, M., Ialchina, R., Hindkær, J., Dyhr, R. T., Bodilsen, A. N., Prasad, N. S., Baldan, J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111956 · Cited by 21
The autophagy-senescence axis as a threshold model of aging and therapeutic targeting
Bahar, M. E., Hwang, J. S., Lai, T. H., Akter, K.-M., Maulidi, R. F., & Kim, D. R. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104079 · Cited by 25
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 23
The intricate nature of senescence in development and cell plasticity
Gal, H., Majewska, J., & Krizhanovsky, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.004 · Cited by 22
Morales-Valencia, J., & David, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.747822 · Cited by 21
Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges
Li, D., Li, Y., Ding, H., Wang, Y., Xie, Y., & Zhang, X. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100439 · Cited by 22
Wan, X., Li, C., Tan, Y. H., Zuo, S., Deng, F. M., Sun, J. F., & Liu, Y. L. (2024) · Cell Biology International · doi:10.1002/cbin.12143 · Cited by 21
Shao, M., Qiu, Y., Shen, M., Liu, W. Q., Feng, D., Luo, Z., & Zhou, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202302547rr · Cited by 27
Construction of biomimetic silver nanoparticles in the treatment of lymphoma
Zhao, Q., Sun, X. Y., Wu, B., Shang, Y., Huang, X., Dong, H., Liu, H., Chen, W., Gui, R., & Li, J. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111648 · Cited by 21
The role of autophagy in escaping therapy-induced polyploidy/senescence
Dudkowska, M., Staniak, K., Bojko, A., & Sikora, E. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.004 · Cited by 22
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
Romaniello, D., Gelfo, V., Pagano, F., Ferlizza, E., Sgarzi, M., Mazzeschi, M., Morselli, A., Miano, C., D’Uva, G., & Lauriola, M. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00319-7 · Cited by 21
Targeting cellular senescence to combat cancer and ageing
Wang, C., Hao, X., & Zhang, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13266 · Cited by 21
Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Khan, S. U., Budamagunta, V., & Zhou, D. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.004 · Cited by 23
Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy
Wang, Y., Wang, L., Wei, Y., Wei, C., Yang, H., Chen, Q., Zhang, R., & Shen, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01049-2 · Cited by 21
Cellular and molecular features of senescence in acute lung injury
Huidobro, C., Martín-Vicente, P., López‐Martínez, C., López-Alonso, I., Amado‐Rodríguez, L., Crespo, I., & Albaiceta, G. M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111410 · Cited by 20
Trayssac, M., Clarke, C. J., Stith, J. L., Snider, J. M., Newen, N., Gault, C. R., Hannun, Y. A., & Obeid, L. M. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03281-4 · Cited by 21
The Potential of Senescence as a Target for Developing Anticancer Therapy
Jo, H., Shim, K., & Jeoung, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043436 · Cited by 20
Zhu, Z., Li, X., Liu, D., & Li, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1140891 · Cited by 20
Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review
Liang, X.-W., Liu, B., Chen, J.-C., Cao, Z. W., Chu, F.-R., Xiong, L., Wang, S.-Z., & Wu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1177466 · Cited by 20
Escape from senescence boosts tumour growth
Medema, J. P. (2017) · Nature · doi:10.1038/d41586-017-08652-0 · Cited by 20
Genotoxic Stress-Induced Senescence
Fan, D. N.-Y., & Schmitt, C. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_10 · Cited by 21
Self-citationSLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness
Robinson, N. J., Morrison-Smith, C. D., Gooding, A. J., Schiemann, B. J., Jackson, M. W., Taylor, D. J., & Schiemann, W. P. (2020) · Life Science Alliance · doi:10.26508/lsa.201900427 · Cited by 20
Capp, J., & Frédéric Thomas, A. (2020) · BioEssays · doi:10.1002/bies.202000140 · Cited by 22
Wiesmann, N., Gieringer, R., Viel, M., Eckrich, J., Tremel, W., & Brieger, J. (2021) · Cancers · doi:10.3390/cancers13122989 · Cited by 21
Huth, H. W., Castro‐Gomes, T., Goes, A. M., & Ropert, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96449-7 · Cited by 20
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.